News

03 Sep 2026

PExA at the world’s largest respiratory congress – three accepted abstracts featuring PExA to be presented

PExA will exhibit at the European Respiratory Society (ERS) International Congress 2026 in Barcelona on 5–9 September. ERS describes the congress as the world’s largest respiratory meeting, regularly attracting around 20,000 participants from across the globe. At the same time, three accepted scientific abstracts featuring PExA technology will be presented, covering research in pulmonary fibrosis…

Read more
19 Aug 2026

PExA receives broad attention in Australia – seen as having significant potential for earlier detection of silicosis

PExA’s technology is receiving broad attention in Australia following promising research at The Prince Charles Hospital in Brisbane. Researchers see potential for a simple, non-invasive breath test to identify early biological changes associated with silicosis – potentially enabling earlier detection and, in the longer term, helping to prevent the disease. During the summer, the research…

Read more
23 Jun 2026

PExA signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million

PExA AB has signed an agreement with one of the world’s ten largest pharmaceutical companies regarding the delivery, installation and rental of ten PExA 2.1 systems for use in an international clinical study in idiopathic pulmonary fibrosis (IPF). Under the agreement, the customer will rent ten systems for a period of 18 months. The total…

Read more
02 Jun 2026

New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases

A new doctoral thesis from Lund University, entirely based on PExA’s technology for analysing exhaled particles from the lungs, strengthens the view of PExA as a platform for non-invasive biomarker analysis. The thesis shows how PExA-based breath samples can provide biologically relevant information across four different areas of lung disease: infection/COVID-19, lung transplantation, acute lung…

Read more

Archive

Categories